September 17, 2007
Takeda Pharmaceutical announced on September 5 that the company has concluded with H. Lundbeck A/S a strategic alliance for the exclusive codevelopment and cocommercialization in the US and Japan of several compounds in Lundbeck's pipeline for the treatment of mood...read more